Max Drawdown (5Y) Chart

Historical Max Drawdown (5Y) Data

View and export this data back to 2011. Start Trial.
Date Value
October 31, 2026 77.82%
September 30, 2026 77.82%
August 31, 2026 77.82%
July 31, 2026 77.82%
June 30, 2026 77.82%
May 31, 2026 77.82%
April 30, 2026 77.82%
March 31, 2026 77.82%
February 28, 2026 77.82%
January 31, 2026 77.82%
December 31, 2025 77.82%
November 30, 2025 77.82%
October 31, 2025 77.82%
September 30, 2025 77.82%
August 31, 2025 77.82%
July 31, 2025 77.82%
June 30, 2025 77.82%
May 31, 2025 77.82%
April 30, 2025 77.82%
March 31, 2025 77.82%
February 28, 2025 77.82%
January 31, 2025 77.82%
December 31, 2024 77.82%
November 30, 2024 77.82%
October 31, 2024 77.82%
Date Value
September 30, 2024 77.82%
August 31, 2024 77.82%
July 31, 2024 77.82%
June 30, 2024 77.82%
May 31, 2024 77.82%
April 30, 2024 77.82%
March 31, 2024 77.82%
February 29, 2024 75.87%
January 31, 2024 75.87%
December 31, 2023 75.87%
November 30, 2023 75.87%
October 31, 2023 75.87%
September 30, 2023 75.87%
August 31, 2023 75.87%
July 31, 2023 75.87%
June 30, 2023 75.87%
May 31, 2023 75.87%
April 30, 2023 75.87%
March 31, 2023 75.87%
February 28, 2023 75.87%
January 31, 2023 75.87%
December 31, 2022 75.87%
November 30, 2022 75.87%
October 31, 2022 75.87%
September 30, 2022 75.87%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Autolus Therapeutics Plc 96.58%
Evaxion AS 99.79%
DBV Technologies SA 98.19%
Cellectis SA 97.08%
Akari Therapeutics Plc 99.83%